Deng S, Zhu G, Liu F. CYP4F2 gene V433M polymorphism is associated with ischemic stroke in the male Northern Chinese Han population. Pro Neuropsychopharmacol Biol Psychiatry 2010:34;664-8.
DOI: 10.1016/j.pnpbp.2010.03.009
Shah M, Adams-Huet B, Franklin B, Phillips M, Mitchell J. The Effects of High-Protein and High-Monounsaturated Fat Meals on Postprandial Lipids, Lipoprotein Particle Numbers, Cytokines, and Leptin Responses in Overweight/Obese Subjects. Metab Syndr Relat Disord 2018;16:150-8.
DOI: 10.1089/met.2017.0167
de Luis DA, Mulero I, Primo D, Izaola O, Aller R. Effects of polymorphism rs3123554 in the CBR2 on metabolic and adiposity parameters after weight loss with two hypocalolric diets. Diab Res and Clin Pract 2018;139:339-47.
DOI: 10.1016/j.diabres.2018.02.030
Peelman F, Verschelde JL, Vanloo B, Ampe C, Labeur C, Tavernier J, Vandekerckhove J, Rosseneu M. Effects of natural mutations in lecithin:cholesterol acyltransferase on the enzyme structure and activity. J Lipid Res 1999;40:59-69.
Li Q, Du Q. Associations between nine candidate genetic polymorphisms with coronary heart disease: A meta-analysis. Herz 2019.
DOI: 10.1007/s00059-019-4806-7
Wu BJ, Sun Y, Ong KL, Li Y, Tang S, Barter PJ, Rye KA. Apo (Apolipoprotein) A-I Protects Against Pregnancy-Induced Insulin Resistance in Rats. Arterioscler Thromb Vasc Biol 2019;ATVBAHA118312282.
DOI: 10.1161/ATVBAHA.118.312282
Larson IA, Ordovás JM, Barnard JR, et al. Effects of apolipoprotein A-I genetic variations on plasma apolipoprotein, serum lipoprotein and glucose levels. Clin Genet 2002;61:176-84.
DOI: 10.1034/j.1399-0004.2002.610302.x
Wang XL, Badenhop RB, Sim AS, Wilcken DE. The effect on transcription efficiency of the apolipoprotein AI gene of DNA variants at the 5′ untranslated region. Int J Clin Lab Res 1998;28:235-41.
DOI: 10.1007/s005990050051
Daneshpour MS, Faam B, Mansournia MA, Hedayati M, Halalkhor S, Mesbah-Namin SA, et al. Haplotype analysis of Apo AI-CIII-AIV gene cluster and lipids level: Tehran Lipid and Glucose Study. Endocrine 2012;41:103-10.
DOI: 10.1007/s12020-011-9526-6
de Franca E, Alves JG, Hutz MH. APOA1/C3/A4 gene cluster variability and lipid levels in Brazilian children. Braz J Med Biol Res 2005;38:535-41.
DOI: 10.1590/S0100-879X2005000400006
López-Miranda J, Ordovás JM, Espino A, et al. Influence of mutation in human apolipoprotein A-1 gene promoter on plasma LDL cholesterol response to dietary fat. Lancet 1994;343:1246.
DOI: 10.1016/S0140-6736(94)92149-0
Phillips CM, Goumidi L, Bertrais S, Field MR, McManus R, Hercberg S, et al. Gene-nutrient interactions and gender may modulate the association between ApoA1 and ApoB gene polymorphisms and metabolic syndrome risk. Atherosclerosis 2011;214:408-14.
DOI: 10.1016/j.atherosclerosis.2010.10.029
de Luis DA, Izaola O, Primo D, Aller R. Role of rs670 variant of APOA1 gene on lipid profile, insulin resistance and adipokine levels in obese subjects after weight loss with a dietary intervention. Diab Res and Clin Pract 2018;142:139-45.
DOI: 10.1016/j.diabres.2018.05.040
Mataix J, Mañas M. Tablas de composición de alimentos españoles. Ed: University of Granada, 2003.
Lukaski H, Johson PE. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 1985;41:810-7.
DOI: 10.1093/ajcn/41.4.810
Friedewald WT, Levy RJ, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
Duart MJ, Arroyo CO, Moreno JL. Validation of an insulin model for the reactions in RIA. Clin Chem Lab Med 2002;40:1161-7.
DOI: 10.1515/cclm.2002.203
Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF: Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-4.
DOI: 10.1007/BF00280883
Meier U, Gressner M. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, Ghrelin, adiponectin, and resistin. Clinical Chemistry 2004;50:1511-25.
DOI: 10.1373/clinchem.2004.032482
Pfutzner A, Langefeld M, Kunt T, Lobig M. Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance. Clin Lab 2003;49:571-6.
Talmud PJ, Ye S, Humphries SE. Polymorphism in the promoter region of the apolipoprotein AI gene associated with differences in apolipoprotein AI levels: the European Atherosclerosis research study. Genet Epidemiol 1994;11:265-80.
DOI: 10.1002/gepi.1370110305
Sigurdsson GJ, Gudnason V, Sigurdsson G, Humphries SE. Interaction between a polymorphism of the ApoA-I promoter region and smoking determines plasma levels of HDL and ApoA-I. Arterioscler Thromb 1992;12:1017-22.
DOI: 10.1161/01.ATV.12.9.1017
Coban N, Onat A, Guclu-Geyik F, Komurcu-Bayrak E, Can G, Erginel-Unaltuna N. Gender-specific associations of the APOA1 -75G>A polymorphism with several metabolic syndrome components in Turkish adults. Clin Chim Acta 2014;431:244-9.
DOI: 10.1016/j.cca.2014.01.017
Akadam-Teker B, Ozkara G, Kurnaz-Gomleksiz O, Bugra Z, Teker E, Ozturk O, et al. BMP1 5'UTR + 104 T/C gene variation: can be a predictive marker for serum HDL and apoprotein A1 levels in male patients with coronary heart disease. Mol Biol Rep 2018;45:1269-76.
DOI: 10.1007/s11033-018-4283-8
Wu JH, Kao JT, Wen MS, Lo SK. DNA polymorphisms at the apolipoprotein A1-CIII loci in Taiwanese: correlation of plasma APOCIII with triglyceride level and body mass index. J Formos Med Assoc 2000;99:367-74.
Pagani F, Sidoli A, Giudici GA, Barenghi L, Vergani C, Baralle FE. Human apolipoprotein A-I gene promoter polymorphism: association with hyperalphalipoproteinemia. J Lipid Res 1990;31:1371-7.
Rai H, Sinha N, Finn J, Agrawal S, Mastana S. Association of serum lipids and coronary artery disease with polymorphisms in the apolipoprotein AI-CIII-AIV gene cluster. Cogent Med 2016;3(1):1266789.
DOI: 10.1080/2331205X.2016.1266789
Morcillo S, Cardona F, Rojo-Martínez G, et al. Association between MspI polymorphism of the APO AI gene and type 2 diabetes mellitus. Diabet Med 2005;22:782-8.
DOI: 10.1111/j.1464-5491.2005.01514.x
Wang X, He J, Guo H, Mu L, Hu Y, Ma J, et al. Interactions of six SNPs in APOA1 gene and types of obesity on low HDL-C disease in Xinjiang pastoral area of China. Lipids Health Dis 2017;16:187.
DOI: 10.1186/s12944-017-0581-8
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: (Adult Treatment Panel III). Jama. 2001;285(19):2486-97.
DOI: 10.1001/jama.285.19.2486
Rudkowska I, Dewailly E, Hegele RA, Boiteau V, Dube-Linteau A, Abdous B, et al. Gene-diet interactions on plasma lipid levels in the Inuit population. Br J Nutr 2013;109(5):953-61.
DOI: 10.1017/S0007114512002231
Moleres A, Milagro FI, Marcos A, González Zorzano E, Campoy C, Garagorri JM, et al. Common variants in genes related to lipid and energy metabolism are associated with weight loss after an intervention in overweight/obese adolescents. Nutr Hosp 2014;30:75-83.
Mata P, López-Miranda J, Pocovi M, Alonso R, Lahoz C, Marín C, et al. Human apolipoprotein A-I gene promoter mutation influences plasma low density lipoprotein cholesterol response to dietary fat saturation. Atherosclerosis 1998;137:367-76.
DOI: 10.1016/S0021-9150(97)00265-7
Hosseini-Esfahani F, Mirmiran P, Daneshpour MS, Mottaghi A, Azizi F. The Effect of Interactions of Single Nucleotide Polymorphisms of APOA1/APOC3 with Food Group Intakes on the Risk of Metabolic Syndrome. Avicenna J Med Biotechnol 2017;9:94-103.
Samson SL, Wong NC. Role of Sp1 in insulin regulation of gene expression. Journal of Molecular Endocrinology 2002;29:265-79.
Wang X, Guo H, Li Y, Wang H, He J, Mu L, et al. Interactions among genes involved in reverse cholesterol transport and in the response to environmental factors in dyslipidemia in subjects from the Xinjiang rural area. PLoS One 201814;13:e0196042.
DOI: 10.1371/journal.pone.0196042
Casillas-Muñoz F, Valle Y, Muñoz-Valle JF, Martínez-Fernández DE, Reynoso-Villalpando GL, Flores-Salinas HE, et al. APOA1 and APOB polymorphisms and apolipoprotein concentrations as biomarkers of risk in acute coronary syndrome: Relationship with lipid-lowering therapy effectiveness. Med Clin (Barc) 2017; S0025-7753(17)30654-1.
DOI: 10.1016/j.medcle.2018.05.001